$19.10
0.412.19%
Pre-Market: 7:40 AM EDT
Comments
Loading...
Mesoblast (MESO) Forecast
NewsEarningsMesoblast (MESO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestMesoblast (NASDAQ:MESO) Stock Quotes, Forecast and News Summary
Mesoblast Stock (NASDAQ: MESO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Mesoblast (MESO) stock?
You can purchase shares of Mesoblast (NASDAQ:MESO) through any online brokerage.
Who are Mesoblast (MESO) competitors?
Other companies in Mesoblast’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), MoonLake (NASDAQ:MLTX), Centessa Pharmaceuticals (NASDAQ:CNTA), SpringWorks Therapeutics (NASDAQ:SWTX) and Protagonist Therapeutics (NASDAQ:PTGX).
What is the forecast, or price target, for Mesoblast (MESO) stock?
Mesoblast has a consensus price target of $9.50.
What is the current price for Mesoblast (MESO)?
The stock price for Mesoblast (NASDAQ: MESO) is $19.1 last updated February 7, 2025 at 7:40 AM EST.
Does Mesoblast (MESO) pay a dividend?
There are no upcoming dividends for Mesoblast.
When is Mesoblast (NASDAQ:MESO) reporting earnings?
Mesoblast’s H1 earnings are confirmed for Friday, February 28, 2025.
Is Mesoblast (MESO) going to split?
There is no upcoming split for Mesoblast.
What sector and industry does Mesoblast (MESO) operate in?
Mesoblast is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.